Responsibilities:
- Develop and execute a territory business plan to meet/exceed sales goals targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and skeletal dysplasia clinic teams.
- Demonstrate deep expertise in Infigratinib and achondroplasia; engage HCPs in clinically relevant, compliant discussions.
- Use sales/target data to identify growth opportunities and address territory challenges proactively.
- Anticipate business challenges, adjust priorities, and develop solutions.
- Partner compliantly with Field Medical, Reimbursement, Family Account Managers, and the HUB to maximize customer/family satisfaction.
- Build relationships with KOLs with Marketing and Medical Affairs to expand advocacy.
- Collaborate across the organization (βOne Bridgeβ mindset) and represent the company with integrity.
- Maintain high proficiency in selling skills, clinical/market/product knowledge, and territory business environment.
- Ensure all activities comply with regulations, company policies, and Pharma guidelines.
Qualifications (Required/Preferred):
- 8β10 years pharma/biotech; 4+ years rare disease/genetic disease/skeletal dysplasia (achondroplasia or pediatric rare disease highly preferred).
- BS/BA required; MBA a plus.
- Willingness to travel extensively.
- Product/indication launch experience; ability to create demand via disease-state/stakeholder education.
- Account management success analyzing complex accounts and delivering measurable impact.
- Strong communication/influence, organizational skills, accountability, judgment.
- AI fluency; integrity/compliance culture commitment.
Benefits (as listed):
- Base pay and annual performance bonus; company equity.
- Health (100% employer-paid medical/dental/vision premiums for you/dependents), HSA/FSA, paid medical & parental leave.
- 401(k) match; ESPP; hybrid flexibility; paid time off and holidays.